Treatments of multi-invasive giant prolactinoma

Journal of Clinical Neuroscience

Volumn 11, Issue 1, 2004, Pages 70-75

  Yang, Meng Yin ^a   Shen, Chiung Chyi ^a   Ho, William L ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Giant pituitary tumour; Prolactinoma; Skull base

Indexed keywords

BROMOCRIPTINE;

AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; CRANIOTOMY; ELECTRON MICROSCOPY; FOLLOW UP; HUMAN; HYPOPHYSIS TUMOR; LONG TERM CARE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TREATMENT OUTCOME;

EID: 0344739826     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2002.11.002     Document Type: Article

References (29)

1. Ariel L, Barkan MD, Wiliam F, Chandler MD. Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "High-dose Hook Effect": Case report. Neurosurgery 1998; 42: 913-916.
2. Bannister P, Sheridan P. Continued growth of a large pituitary prolactinoma despite high dose bromocriptine. Br J Clin Pract 1987; 41: 712-713.
3. Bloom H. Radiotherapy of pituitary tumours. In: Jenkins JS (ed) Pituitary Tumours. Butterworth, London 1973; 165-197.
4. Brediahl HD, Topliss DJ, Pike JW. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma. Br Med J 1983; 287: 451-452.
5. Ciric I, Mikhael M, Stafford T, Lawson L, Garces R. Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 1983; 59: 395-401.
6. Cohen R, Cooper P, Kupersmith M, Flamm E, Ransohoff J. Visual outcome after transsphenoidal removal of pituitary adenomas. Neurosurgery 1985: 17: 446-452.
7. Cohen DL, Diengdoh JV, Thomas DGT, Himsworth RL. An intracranial metastasis from a prolactin secreting pituitary tumour. Clin Endocrinol 1983; 18: 259-264.
8. Flickinger J, Nelson P, Taylor F. Incidence of cerebral infarction after radiotherapy for pituitary adenorna. Cancer 1989; 63: 2504-2508.
9. Fisher BJ, Gaspar LE, Noone B. Giant pituitary adenomas: role of radiotherapy. Int J Radiat Oncol Biol Phys 1993; 25: 677-681.
10. Gasser RW, Fikenstedt G, Skrabal F et al. Multiple intracranial metastases from a prolactin secreting pituitary tumour. Clin Endocrinol 1985; 22: 17-27.
11. Goel A, Nadkarni T. Surgical management of giant pituitary tumours: a review of 30 cases. Acta Neurochir (Wien) 1996; 138: 1042-1049.
12. Grebe SK, Delahunt JW, Feek CM. Treatment of extensively invasive (giant) prolactinomas with bromocriptine. NZ Med J 1992; 105: 129-131.
13. Grossman A, Besser GM. Prolactinomas. Br Med J 1985; 290: 182-184.
14. Laws Jr J, Trautmann J, Hollenburst J. Transsphenoidal decompression of the optic nerve and chiasm-visual results in 62 patients. J Neurosurg 1977; 46: 717-722.
15. Martin NA, Hales M, Wilson CB. Cerebellar metastasis from a prolactinoma during treatment with bromocriptine. J Neurosurg 1981; 55: 615-619.
16. Miyai K, Ichihara K, Kondo K, Mori S. Asymptomatic hyperprolactinemia and prolactinoma in the general population - mass screening by paired assays of serum prolactin. Clin Endocrinol (Oxf) 1986; 25: 549.
17. Mohr G. Hardy J, Comtois R, Beau-regard H. Surgical management of giant pituitary adenomas. Can J Neurol Sci 1990; 17: 62-66.
18. Molitch ME, Elton RL, Blackwell RE et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a multicenter study. J Clin Endocrinol Metab 1985; 60: 698-705.
19. Muphy FY, Vesely DL, Jordan RM, Flanigan S, Kohler PO. Giant invasive prolactinomas. Am J Med 1987; 83: 995-1002.
20. Nabarro JDN. Pituitary prolactinomas. Clin Endocrinal 1982; 17: 129-155.
21. Perani D, Colombo N, Scotti G, Tondon C. Rapid size reduction of giant prolactinoma following medical treatment. J Comp Assist Tomogr 1984; 8: 131-133.
22. Randall R, Laws E, Abboud C, Ebersold M, Kao P, Schiethauer B. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Mayo Clin Proc 1983; 58: 108-121.
23. Scherrer H, Turpin G, De Gennes JL, Schaison Cusin M, Heshmati HM, Thibierge M, Metzger J. Resultats du traitement par Bromocriptine des adenomas prolactine geants ou expansifs: A propos de 20 observations. Ann Med Interne (Paris) 1985; 136: 459-466.
24. Serri O, Rosio E, Beauregard H, Hardy J, Somma M. Recurrence of hyperprolactinemia after transsphenoidal adenomectomy in women with prolactinoma. N Eng J Med 1983; 309: 280-283.
25. Stefanis G, Cavanaugh H, Tindall G. Ophthalmological aspects of pituitary tumours. In: Tindall GJ, Collins WF (eds) Clinical Managements of Pituitary Disorders. Raven Press, New York 1979; 230-263.
26. Thorner MO, Perryman RL, Rogol AD et al. Rapid changes in prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 1981; 53: 480-483.
27. Thorner MO, Schram HF, Evans WS, Rogol AD, Morris J, MacLeod RM. A broad spectrum of prolactin suppression by bromocriptine level after acute and chronic administration of bromocriptine. J Clin Endocrinol Metab 1980; 50: 1026-1033.
28. UHS, Johnso C. Metastatic prolactin-secreting pituitary adenoma. Hum Pathol 1984; 15:94-96.
29. Iwai Y, Hakuba A, Khosla VK, Ch M, Nishikawa M, Katsuyama J, Inoue Y. Giant basal prolactinoma extending into the nasal cavity. Surg Neurol 1992; 37: 280-283.